Saturday 17 October 2026
Export MNDR’s income statement to Excel — free account
Mobile-health Network Solutions
MNDR Healthcare Health Information Services
Mobile-health Network Solutions' revenue for fiscal 2025 (year ended June 2025) was $7.6 million, down 45.3% from fiscal 2024.
0.92
0.17
−15.60%
Follow MNDR
| Jun '22 | Jun '23 | Jun '24 | Jun '25 | |
|---|---|---|---|---|
Piotroski F-Score |
— | — | 5 | 2 |
Altman Z-Score |
— | — | (0.84) | (8.19) |
Altman Z″-Score (non-manufacturers) |
7.79 | (14.77) | (18.88) | (24.34) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
— | (1.66) | (8.06) | 3.35 |
P/Operating CF |
0.00 | 0.00 | 0.00 | 0.00 |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.00 | 0.00 | 0.00 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
0.00 | 0.00 | 0.00 | 0.09 |
EV/FCF |
0.00 | 0.00 | 0.00 | 0.08 |
Quick Ratio |
8.22 | 0.96 | 2.19 | 0.77 |
Current Ratio |
8.31 | 1.09 | 2.31 | 1.06 |
Net Debt/EBITDA |
(36.48) | 0.70 | 0.43 | 0.31 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 1.11 | 2.45 | 1.23 |
Operating CF/Net income |
10.53 | 0.70 | 0.41 | 1.29 |
Capex/Depreciation |
(0.17) | (1.96) | (0.90) | (14.16) |
| 0.00% | (79.65%) | (827.23%) | (100.17%) | |
| 0.00% | (45.27%) | (273.90%) | (54.58%) | |
ROIC |
0.00% | 0.00% | 0.00% | (139.99%) |
Return on Tangible Assets |
1.00% | (810.44%) | (358.95%) | (1,459.79%) |
Average Days of Receivables |
10.10 | 8.40 | 5.08 | 12.81 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
23.67% | 54.46% | 129.53% | 60.85% |
Intangible Assets out of Total Assets |
0.01 | 0.02 | 0.00 | 0.53 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 65.29% | 5.42% |
Graham Net Nets |
0.00 | 0.00 | 0.00 | 0.00 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% | 0.00% |
Revenue per Share |
17,472.00 | 15,749.80 | 97.21 | 51.77 |
Operating CF per Share |
2,439.25 | (4,497.20) | (44.57) | (29.51) |
Capex per Share |
(38.00) | (372.00) | (0.93) | (16.49) |
Free Cash Flow per Share |
2,401.25 | (4,869.20) | (45.51) | (46.01) |
Cash per Share |
25,607.75 | 4,451.60 | 46.68 | 7.00 |
Shareholders Equity per Share |
21,090.25 | (734.40) | 28.81 | 17.72 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
21,090.25 | (734.40) | 28.81 | 17.72 |
Free Cash Flow |
0.96 | (2.43) | (6.54) | (6.80) |
Working Capital |
9.27 | 0.22 | 4.13 | 0.09 |
Capital Expenditures |
(0.02) | (0.19) | (0.13) | (2.44) |
Net Current Asset Value |
8.22 | (1.09) | 3.48 | (0.05) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.02 | 0.01 | 0.32 |
| Other line items | ||||
Depreciation/Fixed assets |
2.53 | 0.53 | 0.69 | 1.24 |
Cash ROIC |
5.14% | (130.99%) | (60.29%) | (186.13%) |
Accounts Receivable Turnover |
0.00 | 42.06 | 74.34 | 33.03 |
Accounts Payable Turnover |
0.00 | 7.06 | 7.54 | 5.01 |
Inventory Turnover |
0.00 | 62.17 | 73.65 | 47.53 |
Average Days of Payables |
40.50 | 73.15 | 53.37 | 49.92 |
Days of Inventory on Hand |
5.18 | 7.88 | 5.24 | 5.96 |
Average Receivables |
— | 0.19 | 0.19 | 0.23 |
Average Payables |
— | 0.96 | 1.52 | 1.27 |
Average Inventory |
— | 0.11 | 0.16 | 0.13 |
Average Assets |
— | 7.10 | 5.70 | 6.20 |
Average Common Equity |
— | 4.03 | 1.89 | 3.38 |
Columns are period end dates